| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 10/09/2001 | US6300355 For therapy of cancer |
| 10/09/2001 | US6300351 For inhibiting human immunodeficiency virus-1 (hiv-1) reverse transcriptase |
| 10/09/2001 | CA2018960C Salicylaldehyde derivatives and salicylic acid derivatives and their sulfur analogs, their preparation and their use as herbicides and bioregulators |
| 10/04/2001 | WO2001073103A2 Preparation of epothilone intermediates |
| 10/04/2001 | WO2001072745A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatmetn of proliferative disorders |
| 10/04/2001 | WO2001072724A1 Synthesis of thiazolium compounds |
| 10/04/2001 | WO2001072723A1 Oxa(thia)zolidine derivative and anti-inflammatory drug |
| 10/04/2001 | WO2001072709A1 Naphtalene derivatives and their pharmaceutical use |
| 10/04/2001 | WO2001072703A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 10/04/2001 | WO2001072702A2 Amidino compounds useful as nitric oxide synthase inhibitors |
| 10/04/2001 | WO2001072694A1 Zofimarin derivatives |
| 10/04/2001 | WO2001072685A2 Polyamine analogues as cytotoxic agents |
| 10/04/2001 | WO2001072290A2 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 10/04/2001 | WO2000034255A9 Substituted thiazoles for treatment of human diseases involving modulators of p-, l- and e- selectin |
| 10/04/2001 | WO2000033836A9 5-membered heterocycles for the treatment of human diseases involving modulators of selectins |
| 10/04/2001 | US20010027211 Anticarcinogenic, -inflammatory and -proliferative agents; viricides; bactericides; vascular restenosis, autoimmune diseases; psoriasis; anticolesterol and -lipemic agents |
| 10/04/2001 | US20010027203 Chemical complex comprising a pyridine carboxy derivative and an H2 histamine receptor antagonist |
| 10/04/2001 | US20010027201 Non-systemic control of parasites |
| 10/04/2001 | US20010027194 Novel compounds useful as neuro-protective agents |
| 10/04/2001 | EP1138328A1 Naphthalene derivatives as CNS drugs |
| 10/04/2001 | EP1137647A1 Thiourea inhibitors of herpes viruses |
| 10/04/2001 | EP1137415A1 Myt1 kinase inhibitors |
| 10/04/2001 | EP0688314B1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use |
| 10/04/2001 | CA2403814A1 Polyamine analogues as cytotoxic agents |
| 10/04/2001 | CA2402288A1 Naphtalene derivatives and their pharmaceutical use |
| 10/04/2001 | CA2401748A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders |
| 10/03/2001 | CN1315873A Prevention/remedies for multiple organ failure |
| 10/03/2001 | CN1072222C Phenyloxazolidinones having C-C bond to 4-8 membered heterocyclic rings |
| 10/03/2001 | CN1072221C 3-halo-3-heteroaryl carboxylic acid derivatives, method of preparing them and intermediates |
| 10/03/2001 | CN1072214C Biologically active benzothiazolone ethanamines |
| 10/03/2001 | CN1072213C Process for producing guanidine derivatives, intermediates therefor |
| 10/02/2001 | US6297374 Nitroimino-nitromethylene—azole or-azine heterocyclic compounds, insecticidal compositions containing them, and insecticidal methods of using them |
| 10/02/2001 | US6297284 Aza-enediyne, aza-enyne allene, or an aza-diallene cationic compounds that bind to nucleic acids. |
| 10/02/2001 | US6297276 Substituted urea and isothiourea derivatives as no synthase inhibitors |
| 10/02/2001 | US6297266 Inhibit the binding of adhesive proteins to the surface of different types of cell and accordingly influence cell-cell and cell-matrix interactions. |
| 09/27/2001 | WO2001070693A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 09/27/2001 | WO2001070677A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 09/27/2001 | WO2001070675A2 Inhibitors of histone deacetylase |
| 09/27/2001 | WO2001070217A1 Dna-cleaving antitumor agents |
| 09/27/2001 | WO2001004115A3 Novel process for synthesis of heteroaryl-substituted urea compounds |
| 09/27/2001 | WO2000061541A3 Pharmaceutical compounds |
| 09/27/2001 | WO2000061537A3 Pharmaceutical compounds |
| 09/27/2001 | US20010025111 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 09/27/2001 | US20010025105 Anticancer agent; Alzheimer's therapy |
| 09/27/2001 | US20010025051 Administering to a breast cancer patient an effective amount of hydroxy containing bicyclic aromatic or heteroaromatic derivatives |
| 09/27/2001 | US20010024833 Reacting resin-bound 1,2-arylenediamine, 2-aminophenol, 2-aminothiophenol, or derivative with cyanogen bromide or aldehyde in the presence of oxidant |
| 09/27/2001 | US20010024749 Surface modified carbonaceous materials |
| 09/27/2001 | CA2404002A1 Inhibitors of histone deacetylase |
| 09/27/2001 | CA2401728A1 Difluorobutyric acid metalloprotease inhibitors |
| 09/26/2001 | EP1135470A2 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 09/26/2001 | EP1135388A2 3-(heterocyclyl)-substituted benzoylpyrazols |
| 09/26/2001 | EP1135378A1 Benzamide derivatives and their use as apob-100 secretion inhibitors |
| 09/26/2001 | EP1135377A1 Novel compounds |
| 09/26/2001 | EP1135128A2 Novel method of treatment |
| 09/26/2001 | EP1135126A2 Myt1 kinase inhibitors |
| 09/26/2001 | EP0934252B1 Amide derivatives and their use as pesticides |
| 09/26/2001 | CN1314899A Retinoid-associated receptor regulators |
| 09/26/2001 | CN1314883A Amino acid derivatives and drug containing the same as the active ingredient |
| 09/26/2001 | CN1314881A Imidamide derivatives |
| 09/26/2001 | CN1071757C Pyrazol benzoyl derivatives |
| 09/25/2001 | US6294580 For therapy and prophylaxis of type ii or non-insulin dependent diabetes mellitus, hyperglycaemia, dyslipidemia, type ii diabetes, type i diabetes, hypertriglyceridemia, syndrome x, insulin resistance, heart failure |
| 09/25/2001 | US6294558 Antiinflammatory agents and prostaglantins |
| 09/25/2001 | US6294374 Use of catalytic antibodies for synthesizing epothilone |
| 09/20/2001 | WO2001068645A2 N-cyanomethylcarboxamides and their use as protease inhibitors |
| 09/20/2001 | WO2001068619A1 5-amide substituted diarylamines as mex inhibitors |
| 09/20/2001 | WO2001068589A1 Acrylonitrile compounds and pest controllers |
| 09/20/2001 | WO2001068586A2 α4β1 AND α4β7 INTEGRIN INHIBITORS |
| 09/20/2001 | WO2001068585A1 Novel amide compounds |
| 09/20/2001 | DE10013306A1 New indeno-dihydrothiazole, naphtho-dihydrothiazole and benzocyclohepta-dihydrothiazole derivatives useful as anorectic agents in the treatment and prevention of obesity and type II diabetes |
| 09/20/2001 | CA2403017A1 5-amide substituted diarylamines as mex inhibitors |
| 09/19/2001 | EP1133485A1 A process for the synthesis of ritonavir |
| 09/19/2001 | EP1133484A2 Heterocyclic derivatives and their use as integrin inhibitors |
| 09/19/2001 | EP1133294A1 Compositions and methods for the treatment of alzheimer's disease, central nervous system injury, and inflammatory diseases |
| 09/19/2001 | EP0923529B1 Substitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 09/19/2001 | EP0775124B1 Herbicidal saccharin carboxylic acid derivatives and method for their preparation |
| 09/19/2001 | EP0612244B1 Endothelin receptor antagonists |
| 09/19/2001 | CN1313856A Thiazoline acid derivatives |
| 09/19/2001 | CN1313855A Inhibitors of alpha4Betal mediated cell adhesion alpha Beta |
| 09/19/2001 | CN1313766A DNA-cleaving antitumor agents |
| 09/19/2001 | CN1313035A Herbicidal composition and use thereof |
| 09/19/2001 | CN1071326C Process for producing chloroacetylaminothizoleacetic acid derivatives |
| 09/19/2001 | CN1071325C Thiol derivatives with metallopeptidase inhibitory activity |
| 09/18/2001 | US6291687 Used aspartyl protease inhibitors of human immunodeficiency virus (hiv) |
| 09/18/2001 | US6291678 Process for the preparation of chiral keto-heterocycles of basic amino acids |
| 09/18/2001 | US6291494 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use |
| 09/18/2001 | US6291493 Use of clomethiazole and salts |
| 09/18/2001 | US6291491 Treatment of type ii diabetes and obesity; antidepressants; decrease gut motility. |
| 09/18/2001 | US6291486 Polycyclic Dihydrothiazoles, their preparation and use as pharmaceuticals |
| 09/18/2001 | US6291463 1-(Benzothiazol-2-yl)-4-(1-phenylmethyl) piperazines: dopamine receptor subtype specific ligands |
| 09/18/2001 | US6291432 (r)-n-(2-methylbenzyl)-3-((2s, 3s)-3-(n-(2-chromonecarbonyl)-l-asparaginyl)amino-2-hydroxy-4-phenylbutano yl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide can be given as a typical example of this compound. |
| 09/18/2001 | US6291400 Herbicidal compounds |
| 09/18/2001 | CA2039056C 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents |
| 09/13/2001 | WO2001066541A1 Process for the preparation of hydrazine derivatives |
| 09/13/2001 | WO2001066534A2 Cyclic and bicyclic diamino histamine-3 receptor antagonists |
| 09/13/2001 | WO2001066532A1 New thiazol compounds and their preparations |
| 09/13/2001 | WO2001066528A1 Method for storing quaternary ammonium salt |
| 09/13/2001 | WO2001012615A3 Fungicidal heteroaryl hepta-2,6-dienoic acid derivatives |
| 09/13/2001 | US20010021716 Using agonist of nicotinergic acetylcholine receptors |
| 09/12/2001 | EP1131310A1 Chrystals of 5- 6-(2-fluorobenzyl)oxy-2-naphthyl methyl]-2,4-thiazolidinedione |
| 09/12/2001 | EP1131308A1 New piperazine and piperidine compounds |